RIVUS PHARMACEUTICALS
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
RIVUS PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Website Url:
http://www.rivuspharma.com
Total Employee:
11+
Status:
Active
Contact:
703-456-8000
Total Funding:
35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Jayson Dallas Executive Chairman @ Rivus Pharmaceuticals
Executive Chairman
2021-04-01
Allen Cunningham Chief Executive Officer @ Rivus Pharmaceuticals
Chief Executive Officer
Francisco Portell VP, Pharmaceutical Development @ Rivus Pharmaceuticals
VP, Pharmaceutical Development
Shaharyar Khan Chief Scientific Officer @ Rivus Pharmaceuticals
Chief Scientific Officer
2019-03-01
Founder
Investors List
RxCapital
RxCapital investment in Series A - Rivus Pharmaceuticals
Longitude Capital
Longitude Capital investment in Series A - Rivus Pharmaceuticals
Medicxi
Medicxi investment in Series A - Rivus Pharmaceuticals
Official Site Inspections
http://www.rivuspharma.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rivus Pharmaceuticals"
Rivus Pharmaceuticals
You have the right to opt out of the provisions of this Arbitration Agreement by sending written notice of your decision to opt out to: Rivus Pharmaceuticals, Inc., 706 Forest Street, Suite B, …See details»
Rivus Pharmaceuticals Strengthens Executive Team and Board with ...
Www.rivuspharma.com. # # # Contact: Meredith Mallen Real Chemistry mmallen@realchemistry.com +1-516-987-2313 References 1. Noureddin M, Khan S, Portell F, …See details»
Rivus Pharmaceuticals - Crunchbase Company Profile & Funding
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health. Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by …See details»
Rivus Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Nov 1, 2024 www.rivuspharma.com. Startups | Holding Company | 2019 | Virginia, United States | 10-50 | www.rivuspharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. …See details»
Rivus Pharmaceuticals Company Profile | Management and
Www.rivuspharma.com Rivus Pharmaceuticals Profile and History Rivus Pharmaceuticals, a leader in mitochondrial biology, is advancing a new class of medicines designed to address a …See details»
Rivus Pharmaceuticals - PitchBook
Rivus Pharmaceuticals General Information Description. Developer of controlled metabolic accelerators designed to improve cardio-metabolic health. The company improves cellular metabolism and treats the underlying cause of …See details»
Rivus Pharmaceuticals CEO and Key Executive Team | Craft.co
Source: rivuspharma.com. Report incorrect company information. Key Executive Tracking. Receive notifications of key executive changes. Get started. Executives of similar companies. …See details»
Rivus Pharmaceuticals - Overview, News & Similar companies
Jun 30, 2023 www.rivuspharma.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Most Recent Scoops. Nov 15 2023. Executive Move. Jul 1 2023. Promotion. Rivus …See details»
Rivus Pharmaceuticals Announces Leadership Transition, …
1 Rivus Pharmaceuticals Announces Leadership Transition, Appointment of Jayson Dallas, M.D., as CEO - Allen Cunningham appointed Chief Operating Officer, guiding execution of the …See details»
Rivus Pharmaceuticals - Craft
Rivus Pharmaceuticals has 5 employees at their 1 location and $35 m in total funding,. See insights on Rivus Pharmaceuticals including office locations, competitors, revenue, financials, …See details»
Rivus Pharmaceuticals | Bain Capital Life Sciences
Rivus Pharmaceuticals is a leader in mitochondrial biology, is dedicated to improving cardiometabolic health by advancing a new class of medicines called controlled metabolic …See details»
Rivus Pharmaceuticals Careers, Perks + Culture | Built In
Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called …See details»
Rivus Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Rivus Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of …See details»
Rivus Pharmaceuticals - VentureRadar
"Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for …See details»
Rivus Pharmaceuticals Overview | SignalHire Company Profile
Organization Website: rivuspharma.com : Social Links: Phone Number: 703-456-8000: Rivus Pharmaceuticals industries Biotech: Rivus Pharmaceuticals Employees Size 10-50 …See details»
Rivus Pharmaceuticals to Present Corporate Update at 2025 J.P.
Media@rivuspharma.com (408) 568-4292 . References. 1. Noureddin M, Khan S, Portell F, et al. Safety and efficacy of oncedaily HU6 versus placebo - in people with non-alcoholic fatty liver …See details»
Rivus Pharmaceuticals, Inc. - CvilleBioHub
Aug 13, 2024 Rivus Pharmaceuticals, a leader in mitochondrial biology, is advancing a new class of medicines designed to address a primary driver of cardio-metabolic diseases: obesity.See details»
Rivus Pharmaceuticals - Products, Competitors, Financials, …
About Rivus Pharmaceuticals. Rivus Pharmaceuticals is a company focused on the treatment of cardio-metabolic diseases. The company's main offerings include oral, once daily, small …See details»
Rivus Pharmaceuticals, Inc. (Rivus Pharmaceuticals, Inc.) - 药物管 …
This randomised, double-blind, placebo-controlled, phase 2a trial was done at a single community site in the USA. Adults (aged 28-65 years) with a BMI of 28-45 kg/m 2, a FibroScan controlled …See details»
What is Rivus Pharmaceuticals? Company Culture, Mission, Values
Glassdoor gives you an inside look at what it's like to work at Rivus Pharmaceuticals, including salaries, reviews, office photos and more. This is the Rivus Pharmaceuticals company profile.See details»